These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Structure-based virtual screening of highly potent inhibitors of the nematode chitinase Chen W; Chen Q; Kumar A; Jiang X; Zhang KYJ; Yang Q J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1198-1204. PubMed ID: 34074203 [TBL] [Abstract][Full Text] [Related]
23. Transglutaminase-catalyzed reaction is important for molting of Onchocerca volvulus third-stage larvae. Lustigman S; Brotman B; Huima T; Castelhano AL; Singh RN; Mehta K; Prince AM Antimicrob Agents Chemother; 1995 Sep; 39(9):1913-9. PubMed ID: 8540691 [TBL] [Abstract][Full Text] [Related]
24. Impact of parental onchocerciasis and intensity of transmission on development and persistence of Onchocerca volvulus infection in offspring: an 18 year follow-up study. Kirch AK; Duerr HP; Boatin B; Alley WS; Hoffmann WH; Schulz-Key H; Soboslay PT Parasitology; 2003 Oct; 127(Pt 4):327-35. PubMed ID: 14636019 [TBL] [Abstract][Full Text] [Related]
25. Cloning of a cysteine protease required for the molting of Onchocerca volvulus third stage larvae. Lustigman S; McKerrow JH; Shah K; Lui J; Huima T; Hough M; Brotman B J Biol Chem; 1996 Nov; 271(47):30181-9. PubMed ID: 8939969 [TBL] [Abstract][Full Text] [Related]
26. DNA immunisation with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice. Harrison RA; Wu Y; Egerton G; Bianco AE Vaccine; 1999 Nov; 18(7-8):647-55. PubMed ID: 10547424 [TBL] [Abstract][Full Text] [Related]
27. Characterization of a novel filarial serine protease inhibitor, Ov-SPI-1, from Onchocerca volvulus, with potential multifunctional roles during development of the parasite. Ford L; Guiliano DB; Oksov Y; Debnath AK; Liu J; Williams SA; Blaxter ML; Lustigman S J Biol Chem; 2005 Dec; 280(49):40845-56. PubMed ID: 16186127 [TBL] [Abstract][Full Text] [Related]
28. Research notes from the Onchocerciasis Chemotherapy Research Centre, Ghana. Awadzi K Ann Trop Med Parasitol; 1997 Oct; 91(7):703-11. PubMed ID: 9625924 [TBL] [Abstract][Full Text] [Related]
29. Immunohistological studies on an Onchocerca volvulus ankyrin (EI). Erttmann KD; Gallin MY; Eggert P; Büttner DW Trop Med Int Health; 1996 Oct; 1(5):558-74. PubMed ID: 8911440 [TBL] [Abstract][Full Text] [Related]
30. Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries. Lizotte-Waniewski M; Tawe W; Guiliano DB; Lu W; Liu J; Williams SA; Lustigman S Infect Immun; 2000 Jun; 68(6):3491-501. PubMed ID: 10816503 [TBL] [Abstract][Full Text] [Related]
31. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466 [TBL] [Abstract][Full Text] [Related]
32. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. Bourguinat C; Pion SD; Kamgno J; Gardon J; Duke BO; Boussinesq M; Prichard RK PLoS Negl Trop Dis; 2007 Aug; 1(1):e72. PubMed ID: 17989786 [TBL] [Abstract][Full Text] [Related]
33. Onchocerca ochengi: morphological identification of the L3 in wild Simulium damnosum s.l., verified by DNA probes. Wahl G; Schibel JM Parasitology; 1998 Apr; 116 ( Pt 4)():337-48. PubMed ID: 9585936 [TBL] [Abstract][Full Text] [Related]
34. [The campaign against onchocerciasis in Africa: update]. Boussinesq M; Hougard JM Med Trop (Mars); 1998; 58(3):285-96. PubMed ID: 10088109 [TBL] [Abstract][Full Text] [Related]
35. Treatment of onchocerciasis. Van Laethem Y; Lopes C Drugs; 1996 Dec; 52(6):861-9. PubMed ID: 8957156 [TBL] [Abstract][Full Text] [Related]
36. Extracts of Euphorbia hirta Linn. (Euphorbiaceae) and Rauvolfia vomitoria Afzel (Apocynaceae) demonstrate activities against Onchocerca volvulus microfilariae in vitro. Attah SK; Ayeh-Kumi PF; Sittie AA; Oppong IV; Nyarko AK BMC Complement Altern Med; 2013 Mar; 13():66. PubMed ID: 23506674 [TBL] [Abstract][Full Text] [Related]
37. Resumption of menstruation in three women with secondary amenorrhoea after treatment with ivermectin. Anosike JC; Abanobi OC Ann Trop Med Parasitol; 1995 Dec; 89(6):693-4. PubMed ID: 8745946 [No Abstract] [Full Text] [Related]
38. Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Hoerauf A; Mand S; Volkmann L; Büttner M; Marfo-Debrekyei Y; Taylor M; Adjei O; Büttner DW Microbes Infect; 2003 Apr; 5(4):261-73. PubMed ID: 12706439 [TBL] [Abstract][Full Text] [Related]
39. Stage-Specific Transcriptome and Proteome Analyses of the Filarial Parasite Onchocerca volvulus and Its Wolbachia Endosymbiont. Bennuru S; Cotton JA; Ribeiro JM; Grote A; Harsha B; Holroyd N; Mhashilkar A; Molina DM; Randall AZ; Shandling AD; Unnasch TR; Ghedin E; Berriman M; Lustigman S; Nutman TB mBio; 2016 Nov; 7(6):. PubMed ID: 27881553 [TBL] [Abstract][Full Text] [Related]
40. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity. MacDonald AJ; Turaga PS; Harmon-Brown C; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S Infect Immun; 2002 Jun; 70(6):2796-804. PubMed ID: 12010965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]